Treatment of multicentric reticulohistiocytosis with adalimumab, minocycline, methotrexate

被引：12
|
作者：
Yeter, Karen C. [1 ]
Arkfeld, Daniel G. [1 ]
机构：
[1] Univ So Calif, Keck Sch Med, Dept Med Rheumatol, Los Angeles, CA 90033 USA
来源：
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2013年 / 16卷 / 01期
关键词：
ARTHRITIS;
D O I：
10.1111/j.1756-185X.2012.01762.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：105 / 106
页数：2
相关论文
共 50 条
  • [21] Development of Methotrexate and Minocycline-Loaded Nanoparticles for the Effective Treatment of Rheumatoid Arthritis
    Kumar Janakiraman
    Venkateshwaran Krishnaswami
    Vaidevi Sethuraman
    Subramanian Natesan
    Vijaya Rajendran
    Ruckmani Kandasamy
    AAPS PharmSciTech, 21
  • [22] Multicentric reticulohistiocytosis (MRH): case report with review of literature between 1991 and 2014 with in depth analysis of various treatment regimens and outcomes
    Tariq, Saad
    Hugenberg, Steven T.
    Hirano-Ali, Stefanie A.
    Tariq, Hassan
    SPRINGERPLUS, 2016, 5 : 1 - 13
  • [23] Metastatic Inflammatory Breast Cancer Associated With Multicentric Reticulohistiocytosis Successfully Treated With Zoledronic Acid
    Varilla, Vincent
    Taxel, Pamela
    Tannenbaum, Susan
    CLINICAL BREAST CANCER, 2016, 16 (06) : E203 - E207
  • [24] Treatment of pediatric uveitis with adalimumab: the MERSI experience
    Castiblanco, Claudia
    Meese, Halea
    Foster, C. Stephen
    JOURNAL OF AAPOS, 2016, 20 (02): : 145 - 147
  • [25] Escalation to Weekly Adalimumab for the Treatment of Ocular Inflammation
    Liberman, Paulina
    Berkenstock, Meghan K.
    Burkholder, Bryn M.
    Chaon, Benjamin C.
    Thorne, Jennifer E.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (7-8) : 1564 - 1568
  • [26] Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate
    Lovell, Daniel J.
    Brunner, Hermine, I
    Reiff, Andreas O.
    Jung, Lawrence
    Jarosova, Katerina
    Nemcova, Dana
    Mouy, Richard
    Sandborg, Christy
    Bohnsack, John F.
    Elewaut, Dirk
    Gabriel, Christos
    Higgins, Gloria
    Kone-Paut, Isabelle
    Jones, Olcay Y.
    Vargova, Veronika
    Chalom, Elizabeth
    Wouters, Carine
    Lagunes, Ivan
    Song, Yanna
    Martini, Alberto
    Ruperto, Nicolino
    RMD OPEN, 2020, 6 (02):
  • [27] Cost per responder of adalimumab biosimilars versus methotrexate in patients with psoriasis: a real-life experience
    Maurelli, Martina
    Girolomoni, Giampiero
    Gisondi, Paolo
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [28] Newly Identified Antiatherosclerotic Activity of Methotrexate and Adalimumab Complementary Effects on Lipoprotein Function and Macrophage Cholesterol Metabolism
    Ronda, Nicoletta
    Greco, Daniela
    Adorni, Maria Pia
    Zimetti, Francesca
    Favari, Elda
    Hjeltnes, Gunnbjorg
    Mikkelsen, Knut
    Borghi, Maria Orietta
    Favalli, Ennio Giulio
    Gatti, Rita
    Hollan, Ivana
    Meroni, Pier Luigi
    Bernini, Franco
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (05) : 1155 - 1164
  • [29] METHOTREXATE IN THE TREATMENT OF RHEUMATOID-ARTHRITIS
    ALAMO, M
    GRISANTI, M
    REVISTA MEDICA DE CHILE, 1991, 119 (06) : 691 - 700
  • [30] Methotrexate: what are the true risks of treatment?
    Strangfeld, Anja
    Burmester, Gerd R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (10) : 1267 - 1268
12345